Brain HealthBlocking the P2X7 Receptor Slashes Brain Inflammation Tied to Alzheimer's and Parkinson's
Researchers at the University of Birmingham have identified the P2X7 receptor as a key driver of harmful brain inflammation linked to Alzheimer's, Parkinson's, traumatic brain injury, and psychiatric conditions like depression and schizophrenia. Working with live human brain tissue and microglia-like cells derived from blood monocytes, the team showed that blocking P2X7 with a specific antagonist significantly cuts cytokine release and the inflammatory cascade. Because drugs that block P2X7 already exist, this discovery opens a fast track toward repurposing them for multiple neurological conditions. The study also introduced a scalable method for generating human microglia in the lab, solving a long-standing research bottleneck.
